Table 3 Log-rank Tests for Prognostic Factors Affecting Overall Survival
From: Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
Factors | P-value |
|---|---|
Gender | 0.077 |
Age (≥ 65 y vs. < 65 y) | 0.238 |
Treatment character (primary vs. recurrent) | 0.725 |
No. of brain metastases (solitary vs. multiple) | 0.189 |
Primary tumor (controlled vs. uncontrolled) | < 0.001 |
Extracranial metastasis (yes vs. no) | 0.453 |
KPS (≥ 80 vs. < 80) | 0.004 |
RPA class | 0.093 |